Cargando…
Author Correction: Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population
Autores principales: | Westphalen, C. B., Krebs, M. G., Le Tourneau, C., Sokol, E. S., Maund, S. L., Wilson, T. R., Jin, D. X., Newberg, J. Y., Fabrizio, D., Veronese, L., Thomas, M., de Braud, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448774/ https://www.ncbi.nlm.nih.gov/pubmed/34535754 http://dx.doi.org/10.1038/s41698-021-00222-y |
Ejemplares similares
-
Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population
por: Westphalen, C. B., et al.
Publicado: (2021) -
NTRK fusions are extremely rare in bone tumours
por: Lam, Suk Wai, et al.
Publicado: (2021) -
Prevalence of NTRK Fusions in Canadian Solid Tumour Cancer Patients
por: Silvertown, Joshua D., et al.
Publicado: (2022) -
Real-world survival outcomes in patients with locally advanced or metastatic NTRK fusion-positive solid tumors receiving standard-of-care therapies other than targeted TRK inhibitors
por: Hibar, Derrek P., et al.
Publicado: (2022) -
Intrapatient comparisons of efficacy in a single-arm trial of entrectinib in tumour-agnostic indications
por: Krebs, M.G., et al.
Publicado: (2021)